NM_018249.6:c.480A>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_018249.6(CDK5RAP2):​c.480A>C​(p.Leu160Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0793 in 1,613,706 control chromosomes in the GnomAD database, including 6,709 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.076 ( 685 hom., cov: 32)
Exomes 𝑓: 0.080 ( 6024 hom. )

Consequence

CDK5RAP2
NM_018249.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -5.55

Publications

25 publications found
Variant links:
Genes affected
CDK5RAP2 (HGNC:18672): (CDK5 regulatory subunit associated protein 2) This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
CDK5RAP2 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • microcephaly 3, primary, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • corpus callosum, agenesis of
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-120539068-T-G is Benign according to our data. Variant chr9-120539068-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5RAP2NM_018249.6 linkc.480A>C p.Leu160Leu synonymous_variant Exon 6 of 38 ENST00000349780.9 NP_060719.4 Q96SN8-1B3KVI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5RAP2ENST00000349780.9 linkc.480A>C p.Leu160Leu synonymous_variant Exon 6 of 38 1 NM_018249.6 ENSP00000343818.4 Q96SN8-1

Frequencies

GnomAD3 genomes
AF:
0.0762
AC:
11589
AN:
152154
Hom.:
686
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0408
Gnomad AMI
AF:
0.0462
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.0689
Gnomad EAS
AF:
0.290
Gnomad SAS
AF:
0.130
Gnomad FIN
AF:
0.0761
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0704
Gnomad OTH
AF:
0.0770
GnomAD2 exomes
AF:
0.0999
AC:
25121
AN:
251412
AF XY:
0.0996
show subpopulations
Gnomad AFR exome
AF:
0.0401
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.0739
Gnomad EAS exome
AF:
0.284
Gnomad FIN exome
AF:
0.0712
Gnomad NFE exome
AF:
0.0741
Gnomad OTH exome
AF:
0.0843
GnomAD4 exome
AF:
0.0797
AC:
116448
AN:
1461434
Hom.:
6024
Cov.:
32
AF XY:
0.0808
AC XY:
58736
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.0355
AC:
1187
AN:
33474
American (AMR)
AF:
0.125
AC:
5570
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0689
AC:
1800
AN:
26130
East Asian (EAS)
AF:
0.289
AC:
11454
AN:
39690
South Asian (SAS)
AF:
0.119
AC:
10279
AN:
86250
European-Finnish (FIN)
AF:
0.0739
AC:
3949
AN:
53402
Middle Eastern (MID)
AF:
0.0638
AC:
368
AN:
5768
European-Non Finnish (NFE)
AF:
0.0688
AC:
76509
AN:
1111632
Other (OTH)
AF:
0.0883
AC:
5332
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
5664
11328
16992
22656
28320
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2936
5872
8808
11744
14680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0761
AC:
11583
AN:
152272
Hom.:
685
Cov.:
32
AF XY:
0.0793
AC XY:
5908
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0407
AC:
1692
AN:
41556
American (AMR)
AF:
0.111
AC:
1702
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0689
AC:
239
AN:
3468
East Asian (EAS)
AF:
0.290
AC:
1499
AN:
5176
South Asian (SAS)
AF:
0.130
AC:
628
AN:
4828
European-Finnish (FIN)
AF:
0.0761
AC:
807
AN:
10610
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0705
AC:
4793
AN:
68012
Other (OTH)
AF:
0.0762
AC:
161
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
529
1058
1588
2117
2646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0686
Hom.:
656
Bravo
AF:
0.0767
Asia WGS
AF:
0.208
AC:
724
AN:
3476
EpiCase
AF:
0.0707
EpiControl
AF:
0.0704

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 02, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary Microcephaly, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.049
DANN
Benign
0.34
PhyloP100
-5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3750494; hg19: chr9-123301346; COSMIC: COSV62572603; COSMIC: COSV62572603; API